Home › Funds › CAXTON CORP › KYTX

CAXTON CORP position in KYTX

KYVERNA THERAPEUTICS INC · Health Care

CAXTON CORP reported holding 12,347 shares of KYTX (KYVERNA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$110K, representing 5.94% of its reported portfolio and ranking #6 among its reported holdings. CAXTON CORP has disclosed KYTX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)12.35K sh
Reported value held$110.01K
Portfolio Weight5.94%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CAXTON CORP's KYTX position evolved

CAXTON CORP first disclosed a stake in KYTX in Q1 2024 at 15,846 shares (US$394K). Across 10 filings, CAXTON CORP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 12,347 shares valued at US$110K — a reduction of -6,426 shares quarter over quarter.. Notable position changes include a 45% increase in Q2 2024 (shares fell 35% over the following quarter), a 34% trim in Q2 2026 (shares fell 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 15.85K $393.61K New
Q2 2024 22.98K $172.36K Add
Q3 2024 22.98K $112.38K Hold
Q4 2024 22.98K $85.95K Hold
Q1 2025 22.98K $44.35K Hold
Q2 2025 22.98K $70.55K Hold
Q3 2025 22.98K $137.89K Hold
Q4 2025 18.77K $176.47K Reduce
Q1 2026 18.77K $162.01K Hold
Q2 2026 12.35K $110.01K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KYTX and 13F data

KYTX (KYVERNA THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in KYTX — the largest reported positions include GordonMD Global Investments LP (US$37.8M), GILEAD SCIENCES, INC. (US$36.8M), Bain Capital Life Sciences Investors, LLC (US$25.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KYTX

All KYTX fund holders →

FAQ

How long has CAXTON CORP held KYTX?

CAXTON CORP has disclosed KYTX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is CAXTON CORP's current position in KYTX?

As of Q2 2026, CAXTON CORP holds 12.35K shares of KYTX (KYVERNA THERAPEUTICS INC), valued at $110.01K, representing 5.94% of its reported portfolio and ranking #6.

Has CAXTON CORP been buying or selling KYTX?

In the latest 13F filing (Q2 2026), CAXTON CORP reduced its position in KYTX.

Which other funds hold KYTX?

Other major institutional holders of KYTX include GordonMD Global Investments LP, GILEAD SCIENCES, INC., Bain Capital Life Sciences Investors, LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.